SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sun Pharmaceutical Industries informs about company updates

24 Dec 2015 Evaluate

Sun Pharmaceutical Industries has informed that Sun Pharma Laboratories, a wholly-owned subsidiary of the Company, has raised, on Private Placement Basis, Rs. 10,000,000,000 by allotment of 10,000 (ICRA) AAA / Stable Outlook Rated Unsecured Redeemable Non-Convertible Debentures of a face value of Rs 1,000,000 each to be listed on under two series with Series 1 debentures comprising of 5,000 debentures amounting to Rupees Five Hundred Crores with a tenor of 24 months, and Series 2 debentures comprising of 5,000 debentures amounting to Rupees Five Hundred Crores with a tenor of 39 months.

The above information is a part of company’s filings submitted to BSE.

Sun Pharma Inds. Share Price

1668.00 -7.20 (-0.43%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1232.25
Cipla 1228.90
Zydus Lifesciences 936.35
Lupin 2328.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×